Mobileye Global Narrows Losses and Raises Guidance Near 52-Week Low
Mobileye Global raised its revenue guidance and narrowed quarterly losses, but the stock sat near 52-week lows as 28.6% short interest signals the market wants proof before pricing in a recovery.
Mobileye Global Narrows Losses and Raises Guidance Near 52-Week Low
NEW YORK, November 7 —
Mobileye Global Inc. (MBLY) lifted revenue guidance and narrowed losses, but the stock sits near 52-week lows with 28.6% of float sold short.
- Revenue guidance raised following Q3 earnings; TTM revenue stands at $2.0bn, down 2.4% YoY
- $672mn in FCF against a $5.73 stock price creates a valuation disconnect the trailing EPS line completely obscures
- Next data point: Q4 revenue direction, with 28.6% short interest amplifying any surprise in either direction
$672mn in Free Cash Flow Makes the Bear Case Harder to Hold
The most underweighted number in the MBLY debate is not the EPS line. Free cash flow of $672mn on $2.0bn in TTM revenue is a 33.6% FCF margin that most semiconductor names would not complain about. The gap between that figure and -$4.92 in trailing EPS points unmistakably to non-cash charges: stock-based compensation and acquired intangible amortization from the Intel spinoff era, which inflate GAAP losses without consuming cash. Any valuation analysis anchored to trailing P/E is measuring the wrong thing.
At $5.73 and 11.8x forward P/E, the market is pricing in an EPS swing from deeply negative to roughly breakeven. That is not irrational if FCF holds and non-cash drag fades, but revenue has to cooperate first.
Revenue Is Still Contracting, and That Is the Only Number That Matters
Guidance lifts only count if they mark an inflection. TTM revenue of $2.0bn represents -2.4% YoY growth, meaning Mobileye is guiding up from a shrinking base. The question the guidance lift does not answer: whether Q4 revenue crosses back into positive YoY territory. If it does, 11.8x forward starts to look conservative. If it does not, $5.73 offers no margin of safety on a name still burning GAAP losses.
Stress-test the range of outcomes with a DCF calculator once management provides specific Q4 targets; the FCF/GAAP divergence makes scenario assumptions unusually consequential here.
Oppenheimer Cut Its Target 41%, and That Tells You Everything About Consensus
Oppenheimer kept its Outperform rating on MBLY but trimmed the price target to $16 from $27, a 41% reduction that signals even the constructive camp is recalibrating its timeline. TD Cowen moved in the opposite direction, downgrading the name outright. Two sell-side shops reaching opposite conclusions on the same earnings print is not noise; it is a sign of genuine model uncertainty about the pace of profitability.
The $16 Oppenheimer target is 2.8x the current price. That gap describes the problem precisely. The stock is not modestly mispriced on one scenario; it is priced for one outcome and catastrophically wrong on the other.
28.6% Short Interest at 52-Week Lows Sets Up an Asymmetric Reaction
Short interest at that level of float is not commentary on fundamentals at this stage; it is a structural feature of the trade. With MBLY already at 52-week lows, shorts are carrying unrealized gains and have less incentive to cover than they would near prior highs. That dynamic inverts fast: a confirmed revenue inflection forces simultaneous covering from a crowded position, and the gap-down visible in the chart becomes the base for the gap-up. The specific number to watch is whether QoQ revenue trends positive in Q4. One confirmed quarter of growth, and the short thesis loses its anchor.
Track MBLY's earnings trajectory, analyst estimate revisions, and margin trends at Mobileye Global on Basis Report.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Mobileye Global (MBLY) reported earnings with narrowed losses and lifted its revenue guidance, reigniting debate over fair value.